QRGenetics

QRGenetics Overview

QRGenetics is the developer of a powerful AI-supported drug discovery engine designed to identify potential therapies for common genetic diseases by uncovering new treatments for patients with similar rare-disease mutations. From Genetic disease without treatment or unknown MOA to precision medicine for populations and address patent cliffs QRGenetics develop a powerful AI-supported drug discovery engine that utilizes exclusive spatial analytics and proprietary datasets, to rapidly discover novel drug-target combinations prompting new applications for soon-expired drugs. QRGenetics’ drug discovery engine utilizes exclusive spatial analytics and proprietary omics datasets to rapidly produce novel drug and target combinations that are effective for multiple indications.

Latest News

Dec 4, 2022 · www.mako.co.il

growth-positive

N12 - פריצת דרך בחקר מחלות גנטיות נדירות: הפלטפורמה שמשלבת AI...

QR Genetics, an Israeli company, has developed a platform that uses artificial intelligence to quickly diagnose genetic mutations and predict which drugs or natural substances will suit patients. The platform was developed in response to a personal family story involving a rare genetic mutation. The company, founded in June 2019, has submitted patent applications for its discoveries and early disease detection capabilities. It has also established relationships with a wide range of medical entities in Israel and around the world. The company plans to treat 50 patients from Israel in the coming year, and grow to 500 patients from Israel and other countries in the following year.

InvestmentExpand

Funding

Team Members

4

Employees: 1-10

Web & Social Links

Locations

Rokach Blvd 97, Tel Aviv-Yafo, Israel

Photos & Videos

No files yet

QRGenetics Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info